中国中医药信息杂志2016，Vol.23Issue(10)：46-50,5.DOI:10.3969/j.issn.1005-5304.2016.10.012
雷公藤多苷片联合抗组胺药治疗慢性荨麻疹系统评价
System Evaluation of Glucoside Tripterygium Total Combined with Antihistamine Medicine for Chronic Idiopathic Urticaria
摘要
Abstract
Objective To systematically evaluate the effectiveness and safety of glucoside tripterygium total (GTT) combined with antihistamine medicine for chronic idiopathic urticaria (CIU). Methods All randomized or semi-randomized controlled trials (RCTs or semi-RCTs) of GTT in treating CIU were collected from CNKI, VIP, WanFang Data, CBM, Embase, PubMed and Cochrane Library clinical controlled trials database. After two researchers conducted screening and data extraction independently, the quality of the included literature research was evaluated according to the risk of bias tool described in the Cochrane Handbook version 5.1.0, and then RevMan 5.3 was used to undertake Meta analysis. Results A total of 21 articles about RCTs and semi-RCTs were obtained, including 2194 patients. Meta analysis indicated that GTT combined with antihistamine medicine treatment showed higher effective rates compared with the control group [RR=1.33, 95%CI (1.26, 1.40), P<0.000 01], with obviously lower recurrence rate [RR=0.45, 95%CI (0.33, 0.62), P<0.000 01]. There was no statistical significance in adverse reactions. Conclusion GTT combined with antihistamine medicine for CIU has definite efficacy, and is relatively safe. Whether apply GTT combined with antihistamine medicine for CIU should be verified through randomized controlled trial with large-scale samples, multiple centers and high quality.关键词
雷公藤多苷片/慢性荨麻疹/系统评价/Meta 分析Key words
glucoside tripterygium total/chronic idiopathic urticaria/systematic review/Meta analysis分类
医药卫生引用本文复制引用
温雯婷,黄晶晶,王鹏丽,虞舜..雷公藤多苷片联合抗组胺药治疗慢性荨麻疹系统评价[J].中国中医药信息杂志,2016,23(10):46-50,5.基金项目
国家中医药管理局中医药标准化项目（ZYYS-2011〔0002〕）；国家中医药管理局中医药科学技术研究专项 （）
